Kerstin Sinkevicius, PhD
Vice President, Pharmacology
Kerstin joined BridgeBio Pharma in May 2021 as Director and Head of Pharmacology and became Vice President of Pharmacology at BBOT in May 2024. Prior to joining BridgeBio, Kerstin was an Associate Director of Pharmacology at KSQ Therapeutics and before that held scientist roles of increasing responsibility at ImmunoGen, Alexion Pharmaceuticals, and Synageva BioPharma. Kerstin has authored sections of 5 INDs and more than 15 peer-reviewed articles.
Kerstin performed her postdoctoral research at Boston Children’s Hospital/Harvard Medical School. She holds a PhD in Cancer Biology from the University of Chicago and a BA in Chemistry from Grinnell College.